Molecular Partners AG

Healthcare

NASDAQ:MOLN · NASDAQ Global Select

Market Cap $139.17M Beta 0.71 P/E (TTM) -2.0

$4.11 +10.78%

+$0.40 today

52W Low $3.41High $5.36

Vol 0.00M · Avg 0.00M

EPS (TTM)-$1.55

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+7.03%

Period High

$5.13

Period Low

$3.47

Latest

$4.11

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Elicio Therapeutics, Inc.

NASDAQ:ELTX

$283.43M

Nkarta, Inc.

NASDAQ:NKTX

$204.62M

Alector, Inc.

NASDAQ:ALEC

$169.87M

Milestone Pharmaceuticals Inc.

NASDAQ:MIST

$109.08M

Cardiff Oncology, Inc.

NASDAQ:CRDF

$105.29M

Corbus Pharmaceuticals Holdings, Inc.

NASDAQ:CRBP

$102.67M

PepGen Inc.

NASDAQ:PEPG

$101.68M

Cassava Sciences, Inc.

SAVA

$63.77M

Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

$49.65M

Applied Therapeutics, Inc.

APLT

$14.86M

What is the latest MOLN filing?

The latest filing shown is 6-K dated Jun 1, 2026.

How many recent filings does MOLN have?

Intrinsic Alpha currently shows 20 recent filings for MOLN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.